Reports on the occurrence of overexpression and increased activity of CACT in prostate cancer as well as abnormal regulation of CACT in bladder cancer contribute to the search for new compounds inhibiting this cotransporter [284,285]. The gene discussed is SLC25A20; the disease is Familial prostate cancer.